A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)
Phase of Trial: Phase III
Latest Information Update: 19 Nov 2008
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 19 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Nov 2005 New trial record.